97 related articles for article (PubMed ID: 21672354)
1. The amount of surface HLA-I on T lymphocytes decreases in breast infiltrating ductal carcinoma patients.
Zhao S; Yang X; Lu N; Zhang Y; Li X; Li Y; Zhou Y; Wan F; Zou X
J Int Med Res; 2011; 39(2):508-13. PubMed ID: 21672354
[TBL] [Abstract][Full Text] [Related]
2. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
3. Gains and losses of HLA class II (DR) and CD4 in atypical hyperplasia, carcinoma in situ and infiltrating ductal carcinoma of the breast.
Tamiolakisl D; Venizelos I; Lambropoulou M; Jivannakis T; Seliniotakis E; Tsikouras P; Limberis V; Tsalkidis A; Papadopoulos N
Acta Medica (Hradec Kralove); 2004; 47(4):257-62. PubMed ID: 15844251
[TBL] [Abstract][Full Text] [Related]
4. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
5. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
Helal TE; Ibrahim EA; Alloub AI
Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
[TBL] [Abstract][Full Text] [Related]
8. CD8+ lymphocytes and apoptosis in typical and atypical medullary carcinomas of the breast.
Nurlaila I; Telisinghe PU; Ramasamy R
Immunol Lett; 2013; 156(1-2):123-6. PubMed ID: 24120509
[TBL] [Abstract][Full Text] [Related]
9. HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.
Keane NM; Pavlos RK; McKinnon E; Lucas A; Rive C; Blyth CC; Dunn D; Lucas M; Mallal S; Phillips E
AIDS; 2014 Aug; 28(13):1891-901. PubMed ID: 24911354
[TBL] [Abstract][Full Text] [Related]
10. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
[TBL] [Abstract][Full Text] [Related]
11. The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study.
Ben-Hur H; Cohen O; Schneider D; Gurevich P; Halperin R; Bala U; Mozes M; Zusman I
Anticancer Res; 2002; 22(2B):1231-8. PubMed ID: 12168931
[TBL] [Abstract][Full Text] [Related]
12. Cancer stage and local immune response.
Murta EF
Immunol Lett; 2014; 159(1-2):79. PubMed ID: 24284374
[No Abstract] [Full Text] [Related]
13. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
[TBL] [Abstract][Full Text] [Related]
14. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
Ryschich E; Nötzel T; Hinz U; Autschbach F; Ferguson J; Simon I; Weitz J; Fröhlich B; Klar E; Büchler MW; Schmidt J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):498-504. PubMed ID: 15701833
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.
Gervais A; Levêque J; Bouet-Toussaint F; Burtin F; Lesimple T; Sulpice L; Patard JJ; Genetet N; Catros-Quemener V
Breast Cancer Res; 2005; 7(3):R326-35. PubMed ID: 15987427
[TBL] [Abstract][Full Text] [Related]
16. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
He X; Dong DD; Yie SM; Yang H; Cao M; Ye SR; Li K; Liu J; Chen J
Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
[TBL] [Abstract][Full Text] [Related]
17. Expression of the genes encoding human leucocyte antigens-A, -B, -DP, -DQ and -G in gastric cancer patients.
Zhang Y; Liu Y; Lu N; Shan NN; Zheng GX; Zhao SM; Zou X; Gao YJ; Li YJ; Wang YS
J Int Med Res; 2010; 38(3):949-56. PubMed ID: 20819431
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on lymphocyte subsets of sentinel lymph nodes in breast cancer patients].
Wang S; Fan P; Wu ZY
Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):220-2. PubMed ID: 15312384
[TBL] [Abstract][Full Text] [Related]
19. The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
Goff SL; Danforth DN
Clin Breast Cancer; 2021 Feb; 21(1):e63-e73. PubMed ID: 32893093
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients.
Feuerer M; Rocha M; Bai L; Umansky V; Solomayer EF; Bastert G; Diel IJ; Schirrmacher V
Int J Cancer; 2001 Apr; 92(1):96-105. PubMed ID: 11279612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
